At the time of writing, Inhibrx Biosciences Inc. [INBX] stock is trading at $14.56, up 4.67%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INBX shares have gain 9.15% over the last week, with a monthly amount drifted -0.07%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
For the past year, the stock price of Inhibrx Biosciences Inc. fluctuated between $10.80 and $18.95. Inhibrx Biosciences Inc. [NASDAQ: INBX] shares were valued at $14.56 at the most recent close of the market.
Analyzing the INBX fundamentals
Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -199.05%, Pretax Profit Margin comes in at 882.65%, and Net Profit Margin reading is 881.76%. To continue investigating profitability, this company’s Return on Assets is posted at 6.32, Equity is 16.18 and Total Capital is -1.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.12 points at the first support level, and at 13.67 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.84, and for the 2nd resistance point, it is at 15.11.
Ratios To Look Out For
It is important to note that Inhibrx Biosciences Inc. [NASDAQ:INBX] has a current ratio of 6.20. As well, the Quick Ratio is 6.20, while the Cash Ratio is 5.81.
Transactions by insiders
Recent insider trading involved MANHARD KIMBERLY, Director, that happened on Aug 28 ’24 when 10000.0 shares were purchased. Director, FORSYTH DOUGLAS completed a deal on Aug 23 ’24 to buy 59812.0 shares. Meanwhile, Director FORSYTH DOUGLAS bought 15188.0 shares on Aug 22 ’24.
